within Pharmacolibrary.Drugs.C_CardiovascularSystem.C01C_CardiacStimulantsExclCardiacGlycosides.C01CA18_Octopamine;

model Octopamine
  extends Pharmacolibrary.Drugs.ATC.C.C01CA18;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C01CA18</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Octopamine is a naturally occurring biogenic amine structurally related to norepinephrine. It acts as a sympathomimetic agent with stimulant properties. Octopamine has been proposed for use in treatment of hypotension and has been investigated as a cardiac stimulant, but it is not approved as a pharmaceutical agent for routine human use in most countries.</p><h4>Pharmacokinetics</h4><p>No direct human pharmacokinetic (PK) studies reporting detailed PK parameters such as volume of distribution and clearance for octopamine could be found in the published literature. The following parameters are estimates based on its chemical similarity to norepinephrine and limited indirect animal or in vitro studies.</p><h4>References</h4><ol><li><p>Raffel, DM, et al., &amp; Quesada, CA (2013). Quantification of cardiac sympathetic nerve density with N-11C-guanyl-meta-octopamine and tracer kinetic analysis. <i>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</i> 54(9) 1645–1652. DOI:<a href=&quot;https://doi.org/10.2967/jnumed.113.120659&quot;>10.2967/jnumed.113.120659</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23886728/&quot;>https://pubmed.ncbi.nlm.nih.gov/23886728</a></p></li><li><p>Hengstmann, JH, et al., &amp; Dengler, HJ (1975). Bioavailability of m-octopamine in man related to its metabolism. <i>European journal of clinical pharmacology</i> 8(1) 33–39. DOI:<a href=&quot;https://doi.org/10.1007/BF00616412&quot;>10.1007/BF00616412</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/786675/&quot;>https://pubmed.ncbi.nlm.nih.gov/786675</a></p></li><li><p>Levy, M (1988). Effects of octopamine on renal function in anaesthetized dogs. <i>Clinical and investigative medicine. Medecine clinique et experimentale</i> 11(6) 396–402. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3147828/&quot;>https://pubmed.ncbi.nlm.nih.gov/3147828</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Octopamine;
